Mbx Biosciences Inc
(MBX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MBX | AZN | AMGN | GILD | BMY |
| Company | Mbx Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 37.51 | 191.80 | 380.70 | 151.85 | 61.37 |
| High | 38.13 | 192.76 | 384.62 | 153.00 | 61.63 |
| Low | 36.49 | 187.06 | 372.34 | 150.18 | 60.36 |
| Latest | 36.87 | 188.68 | 377.04 | 151.84 | 60.70 |
| Change | -0.80 | -4.35 | -7.28 | -0.66 | -1.29 |
| % Change | -2.12% | -2.25% | -1.89% | -0.43% | -2.08% |
| Volume | 224,911 | 2,437,938 | 1,589,208 | 5,115,114 | 8,926,348 |
| 20-Day Average Volume | 809,550 | 4,799,306 | 3,057,015 | 8,078,275 | 13,414,216 |
| Previous Close | 37.67 | 193.03 | 384.32 | 152.50 | 61.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 38.56 | 187.06 | 345.63 | 136.02 | 56.23 |
| 20-Day Raw Stochastic | 39.59% | 62.79% | 88.14% | 94.15% | 82.54% |
| 20-Day Relative Strength | 53.50 | 52.93 | 67.14 | 74.37 | 67.41 |
| Weighted Alpha | +90.87 | +31.95 | +37.90 | +54.31 | +23.86 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 96% Buy | 100% Buy | 96% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.68% since 02/02/26 | -0.19% since 02/02/26 | +9.48% since 02/02/26 | +5.79% since 02/02/26 | +8.36% since 02/02/26 |
| Low | 35.76 on 02/05/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 41.39 on 02/04/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +16.39% since 01/09/26 | -0.66% since 01/09/26 | +15.72% since 01/09/26 | +24.83% since 01/09/26 | +8.42% since 01/09/26 |
| Low | 31.58 on 01/12/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 44.89 on 01/15/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +44.11% since 11/07/25 | +11.17% since 11/07/25 | +17.85% since 11/07/25 | +27.20% since 11/07/25 | +29.72% since 11/07/25 |
| Low | 23.07 on 11/14/25 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 44.89 on 01/15/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +203.04% since 08/08/25 | +27.84% since 08/08/25 | +30.93% since 08/08/25 | +26.60% since 08/08/25 | +31.81% since 08/08/25 |
| Low | 9.63 on 09/12/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 44.89 on 01/15/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,691,458 | 299,371,776 | 206,949,024 | 189,203,696 | 126,196,336 |
| Shares Outstanding, K | 44,902 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -61,920,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -21,620,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.87 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 11/06/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/16/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 16.83 | 18.24 | 9.68 |